𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Promotion of tumor antigenicity in EL-4 leukemia cells by hydrostatic pressure

✍ Scribed by Lysiane Richert; Ayala Or; Meir Shinitzky


Book ID
104660397
Publisher
Springer-Verlag
Year
1986
Tongue
English
Weight
618 KB
Volume
22
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

✦ Synopsis


Subjection of EL-4-1eukemia cells to hydrostatic pressure of 1200-1500atm for 15min increased their weak basal immunogenicity to a potent practical level. Injection of such pressure-treated and irradiated EL-4 cells into syngeneic naive C57B1/6 mice significantly delayed tumor development and increased survival after subsequent challenge with untreated EL-4 cells. Application of pressure of 1500 atm for a longer period of time (e.g., 120 rain) resulted in cell death and a smaller increase in tumor immunogenicity which could be partially accounted for by passive shedding of membrane material. Unlike previously studied tumor cells, incorporation of cholesteryl hemisuccinate (CHS) into the plasma membrane of EL-4 cells increased their apparent tumor immunogenicity only slightly. In addition, isolated EL-4 plasma membranes, untreated, CHS-treated or pressure-treated, as well as the material shed thereof by hydrostatic pressure, were all of weak immunogenicity.

Modulation in the projection of surface antigens upon pressure treatment could account for the observed increase in tumor immunogenicity and was monitored via the Thy 1.2 antigen. Fluorescence cell sorting anylsis indicated that upon application of 1500 atm for different periods of time the projection of Thy 1.2 progressively and irreversibly increased to a maximal level of about 140% at 15 rain. At longer pressurizations the availability of Thy 1.2 to antibody binding decreased sharply to levels below that of the untreated cells. It is suggested that pressure promotion of tumor immunogenicity is induced by changes in projection and surface distribution of the relevant antigens.


πŸ“œ SIMILAR VOLUMES


Presence of CD4+ T suppressor cells in m
✍ Alexander L. Rakhmilevich; Robert J. North; Earl S. Dye πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 French βš– 682 KB

We used in vivo and in vitro assays to determine whether suppressor cells are generated in mice rendered unresponsive to tumor-specific antigens by intravenous (i.v.) injection of non-replicating tumor cells. The results show that a single i.v. injection of 2 X lo7 irradiated P815 tumor cells result

Induction of complete and molecular remi
✍ Van Tendeloo, V. F.; Van de Velde, A.; Van Driessche, A.; Cools, N.; Anguille, S πŸ“‚ Article πŸ“… 2010 πŸ› National Academy of Sciences 🌐 English βš– 350 KB

Active immunization using tumor antigen-loaded dendritic cells holds promise for the adjuvant treatment of cancer to eradicate or control residual disease, but so far, most dendritic cell trials have been performed in end-stage cancer patients with high tumor loads. Here, in a phase I/II trial, we i